Final analysis of a multi-center, double-blind, placebo-controlled, randomized phase II trial of gemcitabine / cisplatin (GC) plus bevacizumab or placebo in patients with malignant mesothelioma. - Karrison,T.; Kindler,H.L.; Gandara,D.R. (Proc Am Soc Clin Oncol, 2007)